Generics

Act4Biosimilars aims to increase patient access to advanced medicines by facilitating greater approvability, accessibility, acceptability and affordability (the four A’s) of biosimilars.

Pemetrexed Lyo. Injection is used to treat non-squamous non-small cell lung cancer and malignant pleural mesothelioma, a cancer of the inside lining of the chest cavity.

The Alimta brand and generic had a market value of approximately $1.2 billion for the most recent 12 months ending in March 2022, according to IQVIA.

Fylentra is used to treat neutropenia, which is commonly experienced by patients undergoing chemotherapy.

Said Darwazah, Hikma’s executive chairman and former CEO, will assume all CEO responsibilities; Hikma’s board has initiated the process to identify a new CEO.

Lexiscan is indicated for radionu lide myocardial perfusion imaging in patients unable to undergo adequate exercise stress.

A distinct set of PBM business practices have resulted in higher prices and delayed access to generics and biosimilars for patients, according to AAM CEO Dan Leonard.

Exemestane tablets have a market value of roughly $29 million for the 12 months ending March 2022, according to IQVIA.